Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymorphisms in Propofol Metabolism
NCT02271542Phase 4Completed
- Sponsor
- Erciyes University
- Start
- Nov 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol injection (veterinary) (3 arms), sponsored by Erciyes University. Primary endpoint: Identification of UGT1A9 and CYP2B6 Polymorphisms. Started Nov 2014; status: completed.
02
Drugs
propofol injection (veterinary)
Beyond the preview
Go deeper on NCT02271542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271542.